Phaxiam is formerly owned by Karista, through Karista HealthTech Fund, since 2018.

When did Karista acquire Phaxiam?

Karista acquired Phaxiam in 2018 and exited after 5 years.

Has Phaxiam been sold?

Yes. Phaxiam was exited in 2023 via IPO.

Home/Companies/Healthcare/Phaxiam

Phaxiam

Healthcare·

France·Exited 2023·Held 5yr

Phaxiam is a TMT company, headquartered in France.

Entry

2018

Hold

5yr

Exit

2023

Est. EV

–

Investor

Karista

Key facts

HQFrance

SectorTMT

Bacteriophage therapeutics formerly Pherecydes; Karista HealthTech entered 2018 and exited 2023 via Euronext merger with Erytech.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Karista HealthTech Fund

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings